TY - CHAP
T1 - Epidemiology of Lassa Fever
AU - Bell-Kareem, Antoinette R.
AU - Smither, Allison R.
N1 - Publisher Copyright:
© 2021, Springer Nature Switzerland AG.
PY - 2023
Y1 - 2023
N2 - Lassa fever (LF) is a lethal hemorrhagic disease primarily concentrated in the tropical savannah regions of Nigeria and the Mano River Union countries of Sierra Leone, Liberia, and Guinea. Endemic hotspots within these countries have had recurrent exposure to Lassa virus (LASV) via continual spillover from the host reservoir Mastomys natalensis. Increased trade and travel throughout the region have spread the virus to previously unexposed countries, including Ghana, Benin, Mali, and Côte d’Ivoire. In the absence of effective treatment or vaccines to LASV, preventative measures against Lassa fever rely heavily on reducing or eliminating rodent exposure, increasing the knowledge base surrounding the virus and disease in communities, and diminishing the stigmas faced by Lassa fever survivors.
AB - Lassa fever (LF) is a lethal hemorrhagic disease primarily concentrated in the tropical savannah regions of Nigeria and the Mano River Union countries of Sierra Leone, Liberia, and Guinea. Endemic hotspots within these countries have had recurrent exposure to Lassa virus (LASV) via continual spillover from the host reservoir Mastomys natalensis. Increased trade and travel throughout the region have spread the virus to previously unexposed countries, including Ghana, Benin, Mali, and Côte d’Ivoire. In the absence of effective treatment or vaccines to LASV, preventative measures against Lassa fever rely heavily on reducing or eliminating rodent exposure, increasing the knowledge base surrounding the virus and disease in communities, and diminishing the stigmas faced by Lassa fever survivors.
UR - http://www.scopus.com/inward/record.url?scp=85165223356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165223356&partnerID=8YFLogxK
U2 - 10.1007/82_2021_234
DO - 10.1007/82_2021_234
M3 - Chapter
C2 - 33861373
AN - SCOPUS:85165223356
T3 - Current Topics in Microbiology and Immunology
SP - 87
EP - 109
BT - Current Topics in Microbiology and Immunology
PB - Springer Science and Business Media Deutschland GmbH
ER -